Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +52.24%
#3 Glidr Glidr +36.41%
#4 Walrus Walrus +29.81%
#5 Cysic Cysic +20.00%
#6 The Black Bull The Black Bull +18.44%
#7 Humanity Humanity +15.87%
#8 Fabric Protocol Fabric Protocol +14.98%
#9 Nockchain Nockchain +14.31%
#10 Tutorial Tutorial +13.13%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Samsrita Labs Ltd. Samsrita Labs Ltd.

Samsrita Labs Ltd.

SAMSRITA
Rank in Stocks #37243
Samsrita Labs Ltd. operates within the healthcare sector, providing a variety... Samsrita Labs Ltd. operates within the healthcare sector, providing a variety of medical services. Its core business activities encompass managing hospital operations, delivering diagnostic services, and engaging in the pharmaceutical and biotechnology fields. The company was founded on January 25, 1996, and its main office is located in Hyderabad, India.
Share Price
$0.12735402
Last synced: 2026-08-14
Market Cap
$1.89M
Change (1 day)
-5.87%
Change (1 year)
-49.65%
Country
IN
Trade Samsrita Labs Ltd. (SAMSRITA)

Category

Healthcare
Revenue for Samsrita Labs Ltd. (SAMSRITA)
Revenue in Aug 2026 TTM: 0
According to Samsrita Labs Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Samsrita Labs Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE